CENTOPHARMA
LIVE

Serial Number

88546263

Owner

Centogene GmbH

Attorney

Angela P. Doughty

Filing Date

Jul 29, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CENTOPHARMA Trademark

Serial Number: 88546263 • Registration: 6127982

CENTOPHARMA is a trademark filed by Centogene GmbH on July 29, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Centogene GmbH (21 trademarks)

Am Strande 7
Rostock 18055 , DE

Entity Type: 99

Centogene AG (16 trademarks)

Am Strande 7
18055 Rostock , DE

Entity Type: 09

Trademark Details

Filing Date

July 29, 2019

Registration Date

August 18, 2020

Published for Opposition

June 2, 2020

Goods & Services

Scientific, surveying, weighing, measuring and checking apparatus and instruments, namely, fluorometers, spectrophotometers, real-time polymerase chain reaction (PCR) devices for gene expression and genotyping, DNA analyzers, DNA fragmentation and capture devices, thermal cycler, and thermal blocks for incubations all to determine the structure, composition or sequence of DNA on multiple genes or on the whole genomic coding region or the whole genome, to determine structure, composition or sequence of RNA and for biochemical measurements of biomarkers; apparatus and instruments for scientific research in laboratories, namely, scientific devices to determine DNA or RNA sequence, alterations, rearrangements, copy number variations, and deletions; apparatus and instruments for scientific research in laboratories, namely, devices to determine biochemical markers, namely, fluorometers, spectrophotometers, real-time polymerase chain reaction (PCR) devices for gene expression and genotyping, DNA analyzers, and DNA fragmentation and capture devices all for scientific purposes; apparatus and instruments for scientific research in laboratories, namely, devices to prepare respective biological samples for acquiring measurements, namely, thermal cyclers, thermal blocks, magnetic beads, pipetting tips, microcentrifuge tubes, and 96-well microplates; pre-recorded compact discs, DVDs, and other digital recording media, namely, downloadable audio and video digital recordings, and digital video media, all featuring clinical phenotypic, genetic molecular and demographic information; computers; downloadable computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instruments

Pharmaceutical preparations for hereditary diseases, metabolic diseases, oncological diseases, and complex multigenic diseases and veterinary preparations for hereditary diseases, metabolic diseases, oncological diseases, and complex multigenic diseases; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratories, for medical and veterinary purposes, namely for detecting genetic predispositions; chemical preparations for analyses in laboratories, for medical or veterinary purposes, namely, nucleic acid and chemical reagents; biological preparations for medical purposes for the treatment of hereditary diseases, metabolic diseases, oncological diseases and complex multigenic diseases; Cultures of microorganisms for medical or veterinary use

Collating and systematic ordering of data in a computer database, namely, database management and computerized file management; Computerized file management; Industrial analysis services, namely, industrial management consultation including cost/yield analyses and marketing research services

Medical and veterinary services, in particular, medical analysis in connection with the treatment of individuals; Providing information in the fields of medicine and veterinary medicine; Health center services, namely, genetic centers providing medical diagnostic, preventive and curative therapy services for genetic disorders, cancer treatment centers, rare disease treatment centers, children's hospitals and women's hospital; Medical clinic services; medical clinic services, namely, medical testing of blood, biological tissue, saliva, urine and hair follicles; gene therapy services in the field of oncology, infertility, prenatal diagnostics, carrier testing, and genetically inherited diseases

Scientific and technological services namely, genetic and biochemical analytical testing for scientific research purposes and new product research and design relating thereto; Industrial analysis services and provision of research services in the field of genetics and in the field of pharmaceutical development; Scientific research for medical purposes in the field of hereditary diseases, oncology, and complex genetics related diseases; Design and development of computer hardware and computer software; Services of a medical laboratory; medical laboratory services for the analysis of samples taken from patients; Provision of information in the field of pharmacology; providing online non-downloadable computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instruments

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 18, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 11, 2020 ASGN
REGISTERED-PRINCIPAL REGISTER
Aug 18, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2020 NONP
ASSIGNED TO LIE
Apr 28, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 21, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 21, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 21, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 21, 2020 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 11, 2020 GNFN
FINAL REFUSAL E-MAILED
Feb 11, 2020 GNFR
FINAL REFUSAL WRITTEN
Feb 11, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 25, 2019 GNRN
NON-FINAL ACTION E-MAILED
Sep 25, 2019 GNRT
NON-FINAL ACTION WRITTEN
Sep 25, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2019 NWOS
NEW APPLICATION ENTERED
Aug 1, 2019 NWAP